ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use i

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
Reply to topic
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use i
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Wed Jul 16, 2008 8:18 am Reply with quote


NEW YORK----ImClone Systems Incorporated , a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that ERBITUX® has received marketing authorization in Japan for use in treating patients with advanced or metastatic colorectal cancer .

Read more...
View user's profileSend private message
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use i
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
 Reply to topic  
Forum Map
Site Map